Inteldefense
The Patent Holiday Is the Easy Part
DoD is offering no-fee licenses to a batch of its patents. The royalty was never the reason these technologies sit on a shelf.
A patent license is a promise not to sue. It is not a product, a team, a customer, or a manufacturing line.
That is the whole problem with a patent holiday, and it is why the Defense Patent Holiday (opens in a new tab) is a sorting exercise rather than an opportunity. The program waives a fee that was rarely the obstacle. Everything that actually blocks commercialization is still in place.
What a no-fee license gives you
DoD-owned patents come out of government laboratories, so the government already owns the invention. A license lets a company practice it. In most technology transfer programs the license is non-exclusive, which means the same patent can be licensed to a competitor next quarter.
That is a reasonable policy. Taxpayers funded the work, and the government should not hand one company a monopoly on a public investment. But it changes the business case completely. A non-exclusive license to an early-stage technology is not a moat. It is a head start that anyone else can buy.
The license also comes with retained government rights. The government can keep using the invention, and can have its contractors use it, for government purposes. If your plan is to sell to DoD, you are selling into a market where your customer already has rights to the thing you licensed.
Three costs that decide the outcome
The fee is the smallest line item. The costs that matter are the ones a license does not reduce.
Technical maturation. A patented invention is usually a proof of concept. Turning it into a product requires engineering, testing, certification, and the unglamorous work of making it reliable outside a laboratory. That is where most of the money goes, and no license waiver touches it.
Manufacturing. A process that works at bench scale often needs different equipment, different tolerances, and a supplier base that does not exist yet. Materials patents are especially prone to this. The formulation can be excellent and the production line can be impossible.
Market development. You are selling something the customer did not know to ask for. That requires pilots, references, and a sales motion. Government customers add another layer: a contracting vehicle, a security review, and a budget cycle.
A company that cannot fund those three costs does not benefit from a free license. It benefits from a clearer view of why it should not start.
The rights problem nobody reads
The license is the beginning of the rights conversation, not the end.
Export control. A technology that is classified or controlled under ITAR has a restricted commercial pathway. The patent being public does not make the technical data public. A company without the right facility posture and export authorizations cannot exploit it, and the license does not grant them.
Security requirements. Some defense technologies carry facility clearance, personnel, and cybersecurity obligations. Those are operating costs that persist for the life of the work.
Retained government rights. The government keeps the rights an owner keeps. It can use the invention, authorize others to use it, and license it again. That can limit exclusivity in the defense market, which is often the only market where the technology has a customer.
Background IP. The patent may be one piece of a working system. If the other pieces are owned by someone else, the license gives you a component and a negotiation.
None of this is a reason to avoid defense technology transfer. It is a reason to read the license before the business plan.
How to screen a batch
Most of the patents in any holiday batch will not be a fit for any particular company. The screen is quick if you are honest about it.
- Is there a customer with a problem, today? Not a market. A named organization with a budget line and a date.
- What is the maturity? A laboratory demonstration, a prototype, or a qualified component. Each one implies a different amount of money before revenue.
- What is the full IP picture? The patent you can license, plus the patents and trade secrets you cannot. If the second list is long, the first one is decoration.
- Can you manufacture it? Not "could it be manufactured." Can your supply chain make it, at the volume the customer needs, at a cost the customer will pay.
- What do the retained rights do to your pricing? If the government can use the invention and license it to your competitor, your price has a ceiling.
Five questions, and most candidates fail at least two.
A holiday is a filter, not a subsidy
The useful thing about a patent holiday is not the waiver. It is the forced inventory. A program office has to list what it owns, describe what it does, and put it in front of people who might use it.
That exercise has value even when nothing gets licensed. It surfaces technologies that were funded, documented, and then forgotten. It creates a record that a company can search. It makes the government's own portfolio legible to the government.
The companies that come out ahead will be the ones that treat the list as a screening problem, not a shopping spree. The rest will license something cheap and discover that the expensive part was never the license.